about
The adventitia: essential regulator of vascular wall structure and functionA Metabolomic Approach to Understanding the Metabolic Link between Obesity and DiabetesA common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular eventsAdenosine 5'-triphosphate stimulates the increase of TGF-beta1 in rat mesangial cells under high-glucose conditions via reactive oxygen species and ERK1/2.P2Y receptors and atherosclerosis in apolipoprotein E-deficient miceExtracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion.20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.P2Y6 receptor-mediated proinflammatory signaling in human bronchial epithelia.Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells.Mechanisms of Platelet Activation and Integrin αIIβ3.Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors.Pharmacological basis of different targets for the treatment of atherosclerosis.Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.P2 receptors in cardiovascular regulation and diseasePurinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR.Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells.CD39 and CD73 in immunity and inflammation.Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death.Purinergic signaling, dyslipidemia and inflammatory disease.Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions.P2 receptors and platelet function.Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cellsP2X7 receptor antagonism modulates IL-1β and MMP9 in human atherosclerotic vesselsShort- and long-term (trophic) purinergic signalling.P2X receptors regulate adenosine diphosphate release from hepatic cells.Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation.Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms.The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells.Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP.Purinergic mechanism in the immune system: A signal of danger for dendritic cells.P2 receptors in atherosclerosis and postangioplasty restenosis.Shaping immune responses through the activation of dendritic cells' P2 receptors.The Impact of Vitamin D3 Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease.P2X7 Receptor and APOE Polymorphisms and Survival from Heart Failure: A Prospective Study in Frail Patients in a Geriatric UnitOverexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.Regulation of innate immunity by extracellular nucleotidesP2X(7) Receptors in Neurological and Cardiovascular Disorders.
P2860
Q27000503-214B992E-4BA6-4751-AAD6-684477AD92D9Q28083355-A0341737-627E-4711-B882-E6096025D3DDQ28729163-0FAAE09A-5CAB-42D6-B72C-F682681661E6Q33556432-16735C64-E29D-4CCB-8AC7-50C711AFE6F1Q33673046-D3391496-031F-4738-997D-96D83304F917Q34271095-5F168AD2-16A8-4E69-998C-B3981BA1EA6CQ35036189-E2169E4E-D092-41ED-9959-A5FC0E1962ACQ35100657-0B69F0DF-F013-4F74-BBF2-91E86C7EA15FQ35268700-E6BC8898-B56D-4C99-B984-DD8B7FDBCE6AQ35890950-5C4E6CBA-B0F2-4239-99FA-2EF5212E0F3EQ36015900-A1752C4F-D999-4C1E-9D56-5DBC7DA18556Q36317194-C67EF5FF-B160-4F0C-8D0F-15C5BCFE066CQ36346487-67D35D2B-CBBB-45DD-9BC9-9EB8D5A173E2Q36357191-CFED8D5C-4230-4C17-A41A-582F1AE8B956Q36464824-DDE099FF-40E7-448D-BF55-903F29C2569EQ36489231-1AA26C64-CA99-40A2-874B-6E35CF2DE431Q36784736-1DF78E02-76C1-4959-BCC6-AA8B12D848CCQ36906658-E88F7C41-D236-45FB-B902-915EF510D27AQ37275036-DAD78CD5-702C-484B-95F5-360D5494F7A0Q37848660-18997F4D-76EE-42EF-9E45-AA8741810DE7Q38055327-9EDE2A2C-40AD-4843-8CD2-DB3A6C9CDA4DQ38151563-67AD3266-DC81-4196-835A-81FDAAAA2F82Q38207600-84EC33B2-BAB4-4852-A8DE-5F0B013528BEQ38306634-7130394C-5DE7-4AF0-ACE2-9F60307C1356Q38502082-22878AA8-2478-4B32-9A89-1C65A005819AQ38688810-180E0366-25BE-40DF-8FEC-297297A250ADQ38885851-03F04E5F-C6BA-48D2-B41E-D2DA8BF5744BQ38971994-B24EF2FA-603D-4B5E-B20B-404AD8008DB4Q39645825-FD819ABE-A263-4FF0-ACF2-236436640DDCQ39701214-E19FF8FA-B017-4F92-AB87-A665FF885414Q40235535-AFBEE602-16CB-41C7-8EA1-801C15DEFFE2Q40538564-7784A872-6014-4E63-A57F-F35B4F6CF168Q40722726-30EBC82B-0E7C-47B3-B682-F7BC605EFE81Q40726298-B29BD7D5-C3BA-44C2-AFE3-EA92B65137C5Q40730253-5F9381D5-56F2-4259-894E-563CCF40F555Q40744623-A1215550-B1DC-4D1B-A5AA-50522508C6D1Q41108747-4012DF90-EF0B-45A7-89B8-5812C4708E0BQ41761170-E453D71F-3B01-4B86-A559-C486DADE5541Q42252932-9D91AD39-9166-45DA-BD52-94BE5DDB09A7Q42265737-2B37E17D-04F3-483E-8524-CA20E1CBAF49
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
P2 receptors: new potential players in atherosclerosis
@ast
P2 receptors: new potential players in atherosclerosis
@en
P2 receptors: new potential players in atherosclerosis
@nl
type
label
P2 receptors: new potential players in atherosclerosis
@ast
P2 receptors: new potential players in atherosclerosis
@en
P2 receptors: new potential players in atherosclerosis
@nl
prefLabel
P2 receptors: new potential players in atherosclerosis
@ast
P2 receptors: new potential players in atherosclerosis
@en
P2 receptors: new potential players in atherosclerosis
@nl
P2860
P356
P1476
P2 receptors: new potential players in atherosclerosis
@en
P2093
Anna Solini
Francesco Di Virgilio
P2860
P304
P356
10.1038/SJ.BJP.0704524
P407
P577
2002-02-01T00:00:00Z